MANILA, Philippines – An independent analysis of financial records belonging to Pharmally Pharmaceutical Corporation, the government’s most favored pandemic supplier, has pointed to a whopping P6.3 billion in tax deficiencies owed to the Bureau of Internal Revenue (BIR).